Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasm Metastasis × pembrolizumab × Clear all

Status

Sponsor Class

Study Type

Interventional 128 Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Melanoma 10 Carcinoma, Non-Small-Cell Lung 10 Lung Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Neoplasms 4 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Urinary Bladder Neoplasms 1 Uncommon Pathological Types of Lung Cancer 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 NSCLC 1 Motor Activity 1 Lung Squamous Cell Carcinoma Stage IV 1 Lung Diseases, Interstitial 1 Liver Diseases 1 Kidney Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Eunuchism 1 Erectile Dysfunction 1 Efficacy, Team 1

Interventions

Blood Specimen Collection 7 Radiosurgery 5 Drug Therapy 5 Therapeutics 4 Surveys and Questionnaires 4 Specimen Handling 4 Radiotherapy 4 Immunotherapy 4 exemestane 3 Hepatectomy 3 Hematologic Tests 3 Docetaxel 3 Data Collection 3 Biological Assay 3 Anastrozole 3 trastuzumab deruxtecan 2 palbociclib 2 enzalutamide 2 apalutamide 2 abiraterone 2 abemaciclib 2 Wearable Electronic Devices 2 Tamoxifen 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Radiofrequency Ablation 2 Prednisone 2 Nivolumab 2 Letrozole 2 Fulvestrant 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03453892 2023-02-16

ST-ICI

University of Erlangen-Nürnberg Medical School

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡